Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2019 Sep 3;84(5):993–1001. doi: 10.1007/s00280-019-03939-7

Figure 1:

Figure 1:

Figure 1:

Histogram Summary of Raw Data. A. Frequency of time after dose (days). B. Frequency of time after dose (days) within the standard 21-day dosing interval. C. Frequency of siltuximab concentrations (mcg/mL). D. Frequency of concentrations less than 50 mcg/mL. The data set represented a broad range of concentrations and time after doses.